Psychopharmacology of autism spectrum disorders: a selective review.
Only two antipsychotics have solid short-term data for autism-related tantrums; everything else rests on tiny, brief trials.
01Research in Context
What this study did
Parsons et al. (2013) read 24 randomized trials on pills for kids with autism. They looked at studies on hyperactivity, tantrums, and aggression.
The team wrote a story-style review. They did not pool numbers; they summed up what each trial said.
What they found
Risperidone and aripiprazole calm tantrums best. Stimulants help some kids focus, but fewer respond than in typical ADHD.
Sleep pills, antidepressants, and antiseizure drugs each had one or two tiny trials. No study ran longer than six months.
How this fits with other research
Hirota et al. (2014) did a meta-analysis of antiepileptic drugs for irritability. They found no benefit over placebo. Sarah’s review had already flagged those same trials as too small and short.
Farmer et al. (2012) showed parent training plus risperidone beats medication alone. Sarah’s paper lists the drug trials; Cristan’s adds the behavioral boost.
Breider et al. (2024) later proved face-to-face parent training beats waitlist for disruptive behaviors. This fills the long-term evidence gap Sarah called for, but with a behavioral instead of pharmacologic fix.
Why it matters
You now know the pill cupboard is half-bare. Use risperidone or aripiprazole only for severe tantrums, monitor weight, and plan to taper. For milder irritability or hyperactivity, try parent training first and track data. Document why you chose the order; the field still lacks long RCTs to back most drug choices.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Graph baseline tantrums this week; if meds start, keep the same behavior plan so you can later show what the drug added or missed.
02At a glance
03Original abstract
While there is no cure for autism spectrum disorder, psychopharmacologic agents are often used with behavioral and educational approaches to treat its comorbid symptoms of hyperactivity, irritability, and aggression. Studies suggest that at least 50% of persons with autism spectrum disorder receive psychotropic medications during their life span. This selective review examines recent studies about the use of psychotropic medications in persons with autism spectrum disorder. The aim was to focus on randomized controlled trials conducted from 1990 to 2010 on this topic. A comprehensive literature search was performed using PubMed and Cochrane databases. Out of 105 studies identified for the review, only 24 were randomized controlled trials. Thus, despite the common use of these medications in autism spectrum disorder, more controlled studies are needed to determine their long-term efficacy and safety.
Autism : the international journal of research and practice, 2013 · doi:10.1177/1362361312453776